Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews · Airways

No studies found 5 · 71.4%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 28.6%Moderate 0 · 0%High 0 · 0%

Frequency and duration of exacerbations · people with bronchiectasis

The review found no eligible studies for this question.

1 finding from 1 review

Mucolytics for bronchiectasis 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Hospitalisations for infective exacerbations · people with bronchiectasis

The review found no eligible studies for this question.

1 finding from 1 review

Mucolytics for bronchiectasis 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adverse events · people with bronchiectasis

The review found no eligible studies for this question.

1 finding from 1 review

Mucolytics for bronchiectasis 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Health‐related quality of life · people with bronchiectasis

The review found no eligible studies for this question.

1 finding from 1 review

Mucolytics for bronchiectasis 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Symptoms mucus volume production · people with bronchiectasis

Erdosteine showed no clear difference in symptoms mucus volume production compared with no treatment (low certainty).

1 finding from 1 review

Mucolytics for bronchiectasis 2014 · Cochrane Headline outcomes only
MD 0.4
1 study · 30 participants
Low

Deaths · people with bronchiectasis

The review found no eligible studies for this question.

1 finding from 1 review

Mucolytics for bronchiectasis 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

FEV1 · people with bronchiectasis

Erdosteine may leads to higher lung function change in FEV1 (L) at day 15 compared with no treatment (low certainty).

1 finding from 1 review

Mucolytics for bronchiectasis 2014 · Cochrane Headline outcomes only
MD 200 [40, 360]
1 study · 30 participants
Low